Publication | Closed Access

Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study

Hemodynamic ImprovementHeart FailureCardiogenic ShockCardiovascular DiseasePharmacotherapyReduced Ejection FractionValvular Heart DiseasePublic HealthMedicineCardiologyAnesthesiology